Moreover, pre-clinical and clinical data regarding the role of DNA methylome alterations in the pathogenesis and treatment modalities of FLT3-ITD AML and potential approaches to target DNA methylation regulators alone or in combination with FLT3Is used in the clinic will be discussed. Here, FLT3 is linked to acute myeloid leukemia.